2,3,7,8-Tetrachlorodibenzo-p-dioxin Activation of the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Pathway Causes Developmental Toxicity through a CYP1A-Independent Mechanism in Zebrafish
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that dimerizes with ARNT to mediate responses to compounds such as 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD). TCDD and other AHR agonists cause toxic responses in early life stages of fish, including the zebrafish, Dan...
Saved in:
Published in | Molecular pharmacology Vol. 66; no. 3; pp. 512 - 521 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Pharmacology and Experimental Therapeutics
01.09.2004
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that dimerizes with ARNT to mediate responses
to compounds such as 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD). TCDD and other AHR agonists cause toxic responses in early life stages of fish, including the zebrafish, Danio rerio . The most well characterized target gene for the AHR/aryl hydrocarbon receptor nuclear translocator (ARNT) dimer is a cytochrome
P450, CYP1A. Induction of CYP1A by TCDD has been correlated with certain toxic responses in developing zebrafish and has been
postulated to mediate these responses. To determine whether CYP1A is the important downstream effector enzyme for the AHR/ARNT
pathway, we used morpholino oligonucleotides (MOs) to block induction of CYP1A in response to TCDD in zebrafish embryos. Although
the zfcyp1a -MO effectively prevented CYP1A up-regulation, it did not prevent the signs of developmental toxicity, including pericardial
edema, slowed blood flow, craniofacial malformation, and defects in erythropoiesis. We conclude that the important target
for the AHR/ARNT pathway in developing zebrafish exposed to TCDD is not zfcyp1a . This suggests an alternative model in which TCDD-activated AHR/ARNT disrupts the normal process of growth and development
by altering programs of gene expression or function. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0026-895X 1521-0111 |